Dental Care Clinics in Peabody, MA Accepting Medicare
43 Dental Care Clinics found. Showing 41 - 43
 Melissa Torres Dds Pllc Dba: Miel Dental Aesthetics Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 300 Andover St Ste 8, Peabody, MA 01960 Phone: 781-595-1713 |
Robert G. Stein, D.m.d., Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 125 Main St, Peabody, MA 01960 Phone: 978-532-1630 Fax: 978-532-5188 |
John A. Pavlo Dmd Pc Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 215 Newbury St, Suite 101, Peabody, MA 01960 Phone: 978-535-5353 |
News Archive
Aspirin may help postmenopausal women reduce risk of trans fat-related stroke
New research shows an increased risk of ischemic stroke in postmenopausal women who consume higher amounts of trans fatty acids, commonly found in baked goods, fried foods, and packaged products. Study findings now available in Annals of Neurology, a journal published by Wiley-Blackwell on behalf of the American Neurological Association and Child Neurology Society, suggest aspirin use may moderate the stroke risk caused by a diet high in trans fats.
CIHR experts offer suggestions for stress-free holiday
The holiday season is synonymous with joy, family and sharing, but it can also mean anxiety, melancholy and illness. With the recent economic downturn and the H1N1 pandemic, many Canadians are facing higher stress levels, sleepless nights and health problems.
FDA, CDC lift recommended pause on the use of Janssen COVID-19 vaccine in the U.S.
Following a thorough safety review, including two meetings of the CDC's Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.
Novartis: Lancet publishes pioneering study of Aimovig's efficacy in episodic migraine patients
Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.
Racial gaps persist in women's heart-health awareness
Racial gaps exist in women's heart-health awareness, women's knowledge of heart attack warning signs requires attention and nearly half of women report they would not call 9-1-1 if they were having heart attack symptoms, according to new research published in Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.
› Verified 8 days ago